jack puymirat
jack puymirat
Unknown affiliation
Verified email at
Cited by
Cited by
Estimating Y chromosome specific microsatellite mutation frequencies using deep rooting pedigrees
E Heyer, J Puymirat, P Dieltjes, E Bakker, P De Knijff
Human molecular genetics 6 (5), 799-803, 1997
Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormone
D Baas, D Bourbeau, LL Sarlieve, ME Ittel, JH Dussault, J Puymirat
Glia 19 (4), 324-332, 1997
Consensus-based care recommendations for adults with myotonic dystrophy type 1
T Ashizawa, C Gagnon, WJ Groh, L Gutmann, NE Johnson, G Meola, ...
Neurology: Clinical Practice 8 (6), 507-520, 2018
Phylogenetic and familial estimates of mitochondrial substitution rates: study of control region mutations in deep-rooting pedigrees
E Heyer, E Zietkiewicz, A Rochowski, V Yotova, J Puymirat, D Labuda
The American Journal of Human Genetics 69 (5), 1113-1126, 2001
Gender as a modifying factor influencing myotonic dystrophy type 1 phenotype severity and mortality: a nationwide multiple databases cross-sectional observational study
C Dogan, M De Antonio, D Hamroun, H Varet, M Fabbro, F Rougier, ...
PloS one 11 (2), e0148264, 2016
Basic transcription element-binding protein (BTEB) is a thyroid hormone-regulated gene in the developing central nervous system: evidence for a role in neurite outgrowth
RJ Denver, L Ouellet, D Furling, A Kobayashi, Y Fujii-Kuriyama, ...
Journal of Biological Chemistry 274 (33), 23128-23134, 1999
Cytoplasmic and nuclear retained DMPK mRNAs are targets for RNA interference in myotonic dystrophy cells
MA Langlois, C Boniface, G Wang, J Alluin, PM Salvaterra, J Puymirat, ...
Journal of Biological Chemistry 280 (17), 16949-16954, 2005
Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts
MA Langlois, NS Lee, JJ Rossi, J Puymirat
Molecular Therapy 7 (5), 670-680, 2003
Identification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1
SK Pandey, TM Wheeler, SL Justice, A Kim, HS Younis, D Gattis, D Jauvin, ...
Journal of Pharmacology and Experimental Therapeutics 355 (2), 329-340, 2015
Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts
D Furling, D Lemieux, K Taneja, J Puymirat
Neuromuscular Disorders 11 (8), 728-735, 2001
Molecular, physiological, and motor performance defects in DMSXL mice carrying> 1,000 CTG repeats from the human DM1 locus
A Huguet, F Medja, A Nicole, A Vignaud, C Guiraud-Dogan, A Ferry, ...
PLoS genetics 8 (11), e1003043, 2012
Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions
ME Arsenault, C Prevost, A Lescault, C Laberge, J Puymirat, J Mathieu
Neurology 66 (8), 1248-1250, 2006
Effect of polyunsaturated fatty acids on fetal mouse brain cells in culture in a chemically defined medium
JM Bourre, A Faivre, O Dumont, A Nouvelot, C Loudes, J Puymirat, ...
Journal of neurochemistry 41 (5), 1234-1242, 1983
Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions
D Furling, G Doucet, MA Langlois, L Timchenko, E Belanger, L Cossette, ...
Gene therapy 10 (9), 795-802, 2003
Thyroid receptors in the rat brain
J Puymirat
Progress in neurobiology 39 (3), 281-294, 1992
Differentiation of fetal mouse hypothalamic cells in serum-free medium
A Faivre-Bauman, E Rosenbaum, J Puymirat, D Grouselle, A Tixier-Vidal
Developmental neuroscience 4 (2), 118-129, 1981
HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence
DH Kim, MA Langlois, KB Lee, AD Riggs, J Puymirat, JJ Rossi
Nucleic acids research 33 (12), 3866-3874, 2005
RNA toxicity in myotonic muscular dystrophy induces NKX2-5 expression
RS Yadava, CD Frenzel-McCardell, Q Yu, V Srinivasan, AL Tucker, ...
Nature genetics 40 (1), 61-68, 2008
Overexpression of the beta 1 thyroid receptor induces differentiation in neuro-2a cells.
JM Lebel, JH Dussault, J Puymirat
Proceedings of the National Academy of Sciences 91 (7), 2644-2648, 1994
Targeting DMPK with antisense oligonucleotide improves muscle strength in myotonic dystrophy type 1 mice
D Jauvin, J Chrétien, SK Pandey, L Martineau, L Revillod, G Bassez, ...
Molecular Therapy-Nucleic Acids 7, 465-474, 2017
The system can't perform the operation now. Try again later.
Articles 1–20